Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
  1. 4 Exercise or conversion President & CEO acquired 124,667 shares (option exercise)
  2. 4 Shares withheld for taxes Chief Medical Officer gave up 2,936 shares (to pay taxes)
  3. 4 Exercise or conversion President & CEO acquired 40,000 shares (option exercise)
  4. 4 Exercise or conversion President & CEO acquired 45,000 shares (option exercise)
  5. 4 Shares withheld for taxes Chief Medical Officer gave up 4,168 shares (to pay taxes)
  6. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $0.96 ($9,600)
  7. 4 Open-market buy President & CEO bought 98,000 shares at $1.06 ($104,027)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Exercise or conversion President & CEO acquired 137,174 shares (option exercise)

Page 12 of 23 · 459 filings